News
XTNT
0.2799
+1.82%
0.0050
Xtant Medical to Announce Third Quarter 2026 Financial Results on November 16, 2026
PR Newswire · 1d ago
Weekly Report: what happened at XTNT last week (1102-1106)?
Weekly Report · 2d ago
Weekly Report: what happened at XTNT last week (1026-1030)?
Weekly Report · 11/02 09:46
Weekly Report: what happened at XTNT last week (1019-1023)?
Weekly Report · 10/26 09:45
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 10/21 12:05
Weekly Report: what happened at XTNT last week (1012-1016)?
Weekly Report · 10/19 09:46
Weekly Report: what happened at XTNT last week (1005-1009)?
Weekly Report · 10/12 09:48
Weekly Report: what happened at XTNT last week (0928-1002)?
Weekly Report · 10/05 09:48
Weekly Report: what happened at XTNT last week (0921-0925)?
Weekly Report · 09/28 09:45
Why the Pentagon Keeps Funding This Small Cap (Nasdaq: MDWD)
TipRanks · 09/22 12:30
Weekly Report: what happened at XTNT last week (0914-0918)?
Weekly Report · 09/21 09:45
Weekly Report: what happened at XTNT last week (0907-0911)?
Weekly Report · 09/14 09:48
Weekly Report: what happened at XTNT last week (0831-0904)?
Weekly Report · 09/07 09:45
Xtant Medical Holdings Initiated at Buy by LUCID CAPITAL MARKETS
Dow Jones · 09/02 13:22
Xtant Medical Holdings Price Target Announced at $1.00/Share by LUCID CAPITAL MARKETS
Dow Jones · 09/02 13:22
LUCID CAPITAL MARKETS Initiates Coverage On Xtant Medical Holdings with Buy Rating, Announces Price Target of $1
Benzinga · 09/02 13:12
Xtant Medical initiated with a Buy at Lucid Capital
TipRanks · 09/02 10:15
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 08/31 21:06
Weekly Report: what happened at XTNT last week (0824-0828)?
Weekly Report · 08/31 09:49
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 08/28 21:06
More
Webull provides a variety of real-time XTNT stock news. You can receive the latest news about Xtant Medical through multiple platforms. This information may help you make smarter investment decisions.
About XTNT
Xtant Medical Holdings, Inc. is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics serving the chronic and surgical wound care and sports medicine markets, as well as spinal implant systems. The Company's products serve the specialized needs of orthopedic and neurological surgeons, as well as trauma, foot and ankle, sports medicine, wound care surgeons including orthobiologics for the promotion of bone healing, amniotic tissue and collagen for both surgical repair and chronic wound care, implants and instrumentation for the treatment of spinal disease. Its orthobiologics products include OsteoSponge, OsteoSelect DBM Putty, OsteoSelect PLUS DBM Putty, 3Demin, OsteoFactor Pro, OsteoVive Plus, and nanOss. Its spinal implant product categories include cervical, thoracolumbar, sacroiliac joint, and interbody. The Company has exclusive United States distribution rights to Dilon's HEMOBLAST Bellows.